Related Experiment Video
Updated: Jun 3, 2026
11:17
Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
Is testing for aspirin response worthwhile in high-risk pregnancy?
Evelyne Rey1, Georges-E Rivard
1Division of Obstetric Medicine, Department of Obstetrics and Gynecology, CHU Sainte-Justine, 3175 Côte Sainte-Catherine, Montreal, QC, Canada H3T 1C5. evelyne_rey@ssss.gouv.qc.ca
Summary
Adjusting aspirin dosage based on platelet function testing (PFA-100®) significantly reduced pre-eclampsia rates in high-risk pregnant women. This individualized approach shows promise for preventing hypertensive disorders during pregnancy.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
- Pharmacology in Pregnancy
Background:
- Hypertensive disorders of pregnancy, including pre-eclampsia, pose significant risks to maternal and fetal health.
- Aspirin (ASA) is commonly used for pre-eclampsia prophylaxis in high-risk pregnancies, but optimal dosing strategies are debated.
- Platelet function monitoring may offer a way to personalize aspirin therapy, but its clinical impact requires investigation.
Purpose of the Study:
- To evaluate the clinical effectiveness of adjusting aspirin dosage based on platelet function analyzer (PFA-100®) monitoring in high-risk pregnant women.
- To compare the incidence of pre-eclampsia, early-onset pre-eclampsia, and severe pre-eclampsia between women managed with and without PFA-100® guided aspirin dosing.
Main Methods:
- Retrospective observational study involving 270 high-risk pregnant women (pre-existing hypertension, diabetes, or prior placental complications).
- Comparison of outcomes between women receiving standard 81 mg aspirin without PFA-100® monitoring and those with individualized aspirin dosing guided by PFA-100® results.
- Aspirin initiation before 13 weeks gestation was common in both groups.
Main Results:
- PFA-100® guided aspirin adjustment was associated with significantly lower rates of pre-eclampsia (15.3% vs. 30.8%) and severe pre-eclampsia (3.6% vs. 15.1%).
- No statistically significant difference in early-onset pre-eclampsia rates was observed between the groups.
- Women requiring increased aspirin dosage had a higher rate of pre-eclampsia compared to those not needing dosage adjustment (25.6% vs. 8.8%).
Conclusions:
- Individualized aspirin dosing guided by platelet function testing appears effective in preventing pre-eclampsia in high-risk pregnancies.
- The findings suggest a potential role for PFA-100® monitoring in optimizing aspirin therapy for pre-eclampsia prevention.
- Further prospective randomized controlled trials are necessary to confirm these results before PFA testing can be considered standard practice.
Related Concept Videos
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:21Factors Affecting Drug Response: Overview
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
01:23Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...